Literature DB >> 33598436

COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy.

Karim Hussien El-Shakankery1, Joanna Kefas1, Rowan Miller2.   

Abstract

Entities:  

Keywords:  COVID-19; cancer; coronavirus; immune checkpoint inhibitors; immunosuppression; immunotherapy; vaccination

Year:  2021        PMID： 33598436      PMCID： PMC7882718          DOI： 10.3389/fonc.2020.631611

Source DB:  PubMed          Journal:  Front Oncol        ISSN： 2234-943X            Impact factor:   6.244


× No keyword cloud information.
  2 in total

1.  Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis.

Authors:  Yifei Ma; Nianqi Liu; Youlong Wang; Jiling Zeng; Ying-Ying Hu; Wu Hao; Huazheng Shi; Pengfei Zhu; Jun Lv; Wei Fan; Xinjia Wang
Journal:  J Immunother Cancer       Date:  2021-11       Impact factor: 13.751

2.  COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology.

Authors:  Enrique Soto-Perez-de-Celis; Oscar Arrieta; Enrique Bargalló-Rocha; Saúl Campos-Gómez; Yanin Chavarri-Guerra; Jessica Chávez-Nogueda; Fernanda González-Lara; Fernando Pérez-Jacobo; Héctor Martínez-Said
Journal:  Arch Med Res       Date:  2021-07-30       Impact factor: 8.323
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.